Heartflow (HTFL) Cash from Investing Activities (2024 - 2025)

Heartflow (HTFL) recorded quarterly Cash from Investing Activities of -$235.4 million in Q4 2025, down 18964.13% quarter-over-quarter from -$1.2 million in Q3 2025, and down 70816.27% on a YoY basis from N/an in Q4 2024.

Heartflow (HTFL) Cash from Investing Activities (2024 - 2025) Analysis & Trends

Heartflow's Cash from Investing Activities history runs 2 years deep, the most recent figure standing at -$235.4 million for Q4 2025.

  • In Q4 2025, Cash from Investing Activities fell 70816.27% year-over-year to -$235.4 million; the TTM figure through Dec 2025 stood at -$238.0 million (changed N/A YoY), while the FY2025 annual figure was -$238.6 million, down 5375.51% from the prior year.
  • Cash from Investing Activities was -$235.4 million for Q4 2025 at Heartflow, down from -$1.2 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$332000.0 in Q4 2024 to a low of -$235.4 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Veeva Systems 26.11 Bn 18.79 Bn 662.02 Mn -388.71 Mn
2 BrightSpring Health Services 12.95 Bn 12.07 Bn 482.22 Mn 747.39 Mn
3 Healthequity 7.46 Bn 7.19 Bn 256.31 Mn -13.90 Mn
4 Hinge Health 5.15 Bn 4.83 Bn 154.23 Mn 48.08 Mn
5 Doximity 3.75 Bn 3.00 Bn 125.97 Mn 137.98 Mn
6 10x Genomics 3.69 Bn 3.15 Bn 106.18 Mn -1.31 Mn
7 Waystar Holding 3.61 Bn 3.45 Bn 268.04 Mn -112.49 Mn
8 Privia Health 2.90 Bn 2.54 Bn 595.71 Mn -26,000.00
9 Omnicell 1.72 Bn 1.54 Bn 140.36 Mn -15.87 Mn
10 Heartflow 1.23 Bn 1.05 Bn 39.06 Mn -235.44 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -235.44 Mn
Dec 31, 2025 -235.44 Mn
Sep 30, 2025 -1.24 Mn
Sep 30, 2025 -1.24 Mn
Dec 31, 2024 -332,000.00
Dec 31, 2024 -332,000.00
Sep 30, 2024 -1.02 Mn
Sep 30, 2024 -1.02 Mn